GlaxoSmithKline Pharmaceuticals Limited has recommended a dividend of INR 32/- per equity share on face value of INR 10 each for the year ended 31 March 2024, subject to approval of members at 99th Annual General Meeting. The Company has fixed 31 May 2024, as the Record Date for determining entitlement of members to final dividend for the financial year ended 31 March, 2024. If the final dividend as recommended by the Board of Directors is approved at the AGM, payment of such dividend, subject to deduction of tax at source, will be made on and after 1st July 2024.